11th January 2019, Hyderabad, India: Hetero, one of India’s leading Indian generic pharmaceutical company and the globally biggest manufacturer of anti-retroviral drugs, announce the release of generic version of Lapatinib (250 mg) tablets in India.
What is lapatinib used for?
Lapatinib is used to treat advanced metastatic breast cancer. Lapatinib is useful for those patients who have already
been treated with other chemotherapy medications.
Is Lapatinib generic available?
Lapatinib generic is available in India. In India some of the pharmaceutical companies manufacture
generic version of Lapatinib. Hetero Labs is one of them.
The product is advertised and distributed by the brand name ‘HERTAB’ via Hetero Healthcare Ltd, one of the leading generic manufacturer in India.
Hertab (Generic Lapatinib) available in two SKUs, each along with 30 pills and 150 tablets.
HERTAB generic Lapatinib is an oral remedy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy.
The tablets are utilized along with Capecitabine or Letrozole, which collectively, inhibit the growth of cancer cells in patients, Hetero stated.
Natco Generic Lapatinib (Herduo)
Natco Pharma, India a FDA, WHO, GMP certified company also have the generic version of Lapatinib with the brand name of Herduo 250 mg tablets.
How much does Lapatinib cost in India?
Lapatinib cost in India is very low as compare to the international market price.
Many patients all around the world prefer Indian generic Lapatininb from India.